- Exchanges
- BSE, NSE
- Industry
- Hospital
- Issue
- Book building
GPT Healthcare IPO
₹200.70
+7.90% on listing
Listing-day close · NSE · 29 Feb 2024 · issue price ₹186
GPT Healthcare’s ₹525 crore IPO was priced at ₹186 a share. It listed on the NSE on 29 Feb 2024 and closed its first day at ₹200.70, up 7.90% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹525 Cr
- Fresh issue
- ₹40 Cr
- Offer for sale
- ₹485 Cr
- Lot size
- 80 shares
- Minimum investment
- ₹14,880
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 6.26× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹1,526 Cr
- P/E (post-issue)
- 32.5
- EPS (post-issue)
- ₹0.00
- Price to book
- 9.1
- ROE
- 23.59%
- ROCE
- 26.09%
- Debt to equity
- 0.39
- PAT margin
- 10.64%
- Promoter holding
- 67.34% → 65.57%
From the offer documents.
Listing
- Listing date
- 29 Feb 2024
- Issue price
- ₹186
- Open
- ₹215.00
- High
- ₹219.90
- Low
- ₹196.10
- Close
- ₹200.70
Listing day on the NSE. The close was +7.90% on the issue price.
GPT Healthcare share price todayFAQs
When did the GPT Healthcare IPO open and close?
It opened on 22 Feb 2024 and closed on 26 Feb 2024.
What was the GPT Healthcare IPO price?
The price band was ₹177–186 a share. The final issue price was ₹186.
What is the lot size and minimum investment?
One lot is 80 shares, ₹14,880 at ₹186 a share. Retail investors apply in whole lots.
How much did GPT Healthcare raise?
₹525 crore: ₹40 crore of new shares and ₹485 crore offered by existing shareholders.
How many times was the GPT Healthcare IPO subscribed?
6.26 times overall.
How did GPT Healthcare list?
It listed on the NSE on 29 Feb 2024 at ₹215.00 and closed the day at ₹200.70, up 7.90% on the ₹186 issue price.
Who is the registrar of the GPT Healthcare IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app